USANA Health Sciences, Inc.
USNA
$27.18
$0.080.30%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 42.03M | 54.34M | 55.08M | 61.94M | 63.79M |
| Total Depreciation and Amortization | 22.23M | 21.22M | 20.82M | 20.26M | 20.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.74M | 13.39M | 13.54M | 12.56M | 14.46M |
| Change in Net Operating Assets | -13.00M | -7.72M | -15.51M | -19.27M | -28.00M |
| Cash from Operations | 60.99M | 81.23M | 73.93M | 75.49M | 70.64M |
| Capital Expenditure | -10.07M | -15.60M | -14.65M | -15.59M | -14.49M |
| Sale of Property, Plant, and Equipment | 64.00K | 66.00K | 5.00K | 18.00K | 15.00K |
| Cash Acquisitions | -203.34M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 255.00K | 255.00K | 255.00K | 2.91M | 2.50M |
| Cash from Investing | -213.09M | -15.27M | -14.39M | -12.67M | -11.98M |
| Total Debt Issued | 23.69M | 1.48M | 1.48M | 2.08M | 1.54M |
| Total Debt Repaid | -1.47M | -1.47M | -1.48M | -750.00K | -750.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -12.67M | -12.73M | -24.29M | -24.31M | -14.69M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -338.00K |
| Cash from Financing | 9.55M | -12.72M | -24.28M | -22.98M | -14.24M |
| Foreign Exchange rate Adjustments | -6.19M | 4.68M | -3.02M | -7.10M | -2.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.74M | 57.92M | 32.23M | 32.74M | 41.93M |